AI Portfolio Summary
In 2025 Q4, Data Collective IV GP, LLC maintained a portfolio of 4 distinct positions. Conversely, Data Collective IV GP, LLC completely exited their position in Roivant Sciences Ltd.
Total Positions
4
Quarter
2025 Q4
Top Holding
EVLV (56.2%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-4 of 4
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EVLV
Evolv Technolog...
|
Industrials | 56.17% | 55.53% |
#1
Prev: #1
|
6.5 | -410,000 | -8.2% |
P
S
|
4,590,000 | $32,864,400 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RXRX
Recursion Pharm...
|
Healthcare | 41.53% | 42.65% |
#2
Prev: #2
|
6.5 | no change | no change |
P
S
|
5,941,120 | $24,299,181 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MNMD
Mind Medicine (...
|
Healthcare | 2.30% | 1.74% |
#3
Prev: #3
|
2.9 | no change | no change |
P
S
|
100,350 | $1,343,687 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ROIV
Roivant Science...
|
Healthcare | 0.00% | 0.09% |
Sold All 😨
(Was: #4) |
0.0 | -3,875 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-4 of 4 holdings